Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

293780.KQ

STRONG SELL

AptaBio Therapeutics Inc. · Healthcare · South Korea · $91M · Avg Vol: $414K/d

3
StockRank
Q
24
V
37
M
16
P/E (TTM)
—
ROE
-43.6%
D/E
0.1x
Dividend %
—
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →

COMPANY DESCRIPTION

AptaBio Therapeutics Inc., a biopharmaceutical company, develops platform based drugs for intractable diseases.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue31,829213,1892M2M324.5%
EPS-0.31-0.35-0.82-0.40—
Shares22M22M27M27M+20.6%
Debt240,9449M5M3M129.5%
Equity34M40M36M31M-3.4%
Op CF-4M-9M-8M-10M—
Inv CF1M-8M8M4M—
Fin CF326,50533M-110,131-446,757—
Loading...
PRICE (1M)-42.2%
3.113.684.254.825.39May 6May 28Jun 18
SMA 50SMA 200
Close
$3.11
RSI (14)
18.1
52W High
$7.87
From 52W High
0.4%

SCORE BREAKDOWN

Quality
24
ROIC
-26.3%24.9
ROE
-43.6%19.6
GP/Assets
2.9%15.4
Op. Margin
-636.6%9.4
FCF/Assets
-32.1%8.1
Piotroski
—7.2
Int. Cover
-6.2x29.2
D/E Ratio
0.11x64.2
Current Ratio
1.72x31.1
Value
37
P/E (TTM)
—N/A
EV/EBITDA
-7.2x77.7
P/FCF
—N/A
P/B
2.9x41.4
P/S
32.6x12.3
Div Yield
—N/A
Momentum
16
52W High %
40%12.0
RS 6M
-170%1.0
SMA 50/200
0.87x25.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$91M
P/E (Forward)
—
Gross Margin
40.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 293780.KQ are excluded.

TickerCompanyMkt CapStockRankSignal
293780.KQAptaBio Therapeutics Inc.(you)$91M3STRONG SELL
067080.KQDAE HWA Pharmaceutical Co., Ltd.$127M7STRONG SELL
092040.KQAmicogen, Inc.$58M7STRONG SELL
000520.KSSamil Pharmaceutical Co.,Ltd$105M14STRONG SELL
058820.KQCMG Pharmaceutical Co., Ltd.$107M14STRONG SELL
032300.KQKOREA PHARMA Co., Ltd.$63M12STRONG SELL
003520.KSYungjin Pharm. Co., Ltd.$158M10STRONG SELL
002390.KSHANDOK Inc.$73M17STRONG SELL
063160.KSCKD Bio Corp.$62M15STRONG SELL
220100.KQFutureChem Co.,Ltd$222M6STRONG SELL

Peer medians: ROE -1.1% · P/E 17.7x · Gross margin 43.6%

AptaBio Therapeutics Inc. (293780.KQ) — Stock Score Summary

AptaBio Therapeutics Inc. (293780.KQ) has a MoatMap StockRank of 3/100 based on Quality (24/100), Value (37/100), and Momentum (16/100) factor scores. The current signal is STRONG SELL.

AptaBio Therapeutics Inc., a biopharmaceutical company, develops platform based drugs for intractable diseases.

Key Financial Metrics

Price$3.11
Market Cap$91M
Price/Book2.89
Return on Equity-43.6%
Return on Invested Capital-26.3%
Debt/Equity11.39
Gross Margin40.2%
Operating Margin-636.6%
Revenue Growth150.2%
Free Cash Flow$-8K

AptaBio Therapeutics Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is AptaBio Therapeutics Inc.’s (293780.KQ) StockRank?
MoatMap’s StockRank for AptaBio Therapeutics Inc. (293780.KQ) is 3/100, with a Strong Sell signal. It is a composite of Quality (24), Value (37), and Momentum (16) factor ranks across MoatMap’s 20,000+ stock universe.
Does AptaBio Therapeutics Inc. have an economic moat?
AptaBio Therapeutics Inc. (293780.KQ) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AptaBio Therapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for AptaBio Therapeutics Inc. (293780.KQ) is Strong Sell, based on a StockRank of 3/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AptaBio Therapeutics Inc. in?
AptaBio Therapeutics Inc. (293780.KQ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks293780.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock